StocksFin Logo
Bio-Techne Corporation country of incorporation
|
|
Mr. Charles Kummeth
|
3,000 employees
NASDAQ | Healthcare | Biotechnology
Henry Schein, Inc. country of incorporation
|
|
Mr. Stanley Bergman
|
22,000 employees
NASDAQ | Healthcare | Medical Distribution
Q123 reported Nov 7, 2022 Reporting Period
$269.66M 4.6% vs. Q122 Revenues Q123
66.6% 0.4% vs. Q122 Gross Profit Margin
33.21% 22.9% vs. Q122 Net Profit Margin
46.53M -3.9% vs. Q122 Free Cash Flow Q123
$0.55 30.6% vs. Q122 EPS Q123
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
0.11%
Q122
Q122 reported May 3, 2022 Reporting Period
$3.18B 8.7% vs. Q121 Revenues Q122
30.61% 0.5% vs. Q121 Gross Profit Margin
5.69% 0.3% vs. Q121 Net Profit Margin
74M 16.8% vs. Q121 Free Cash Flow Q122
$1.31 12% vs. Q121 EPS Q122
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q123
0.11%
Q122
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Mar 31, 2022
Quick Ratio
2.74
0.73
Current Ratio
4.01
1.79
Cash Ratio
1.2
0.06
Price to Book
6.36
3.33
Price to Sales
41.32
3.77
Price to Earnings
31.1
16.53